FDA.reportPublic FDA data

Orilissa 150 MG Oral Tablet

RxCUI
2049858
RxNorm name
Orilissa 150 MG Oral Tablet
Display name
Orilissa 150 MG Oral Tablet
Full name
Orilissa 150 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OrilissaELAGOLIXAbbVie Inc.a86757b3-09c5-fd3b-1223-244e94f50a662025-12-19Warnings, Adverse reactionsExact identifier
rxcui: 2049858

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a86757b3-09c5-fd3b-1223-244e94f50a66Orilissa 150 MG Oral Tablet [PSN] · elagolix 150 MG Oral Tablet [Orilissa] [SBD] · Orilissa 150 MG Oral Tablet [SY]3111These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA ® (elagolix) tablets, for oral use Initial U.S. Approval: 201820251219